Mentions légales et Charte du site

Vous êtes actuellement connecté au site Internet officiel de Gustave Roussy.

Informations éditeur

Ce site est édité par Gustave Roussy.

Adresse juridique
Institut Gustave Roussy
39 bis, rue Camille Desmoulins
94805 Villejuif Cedex
N° SIRET : 775 741 101 00031

Directeur de la publication
Professeur Fabrice Barlesi
Directeur général de Gustave Roussy

Bioinformatics core facility - Lab members

• Head of the bioinformatics core facility: Marc Deloger (marc.deloger@gustaveroussy.fr)

• "Core Service" bioinformaticians (permanent employees): Thibault Dayris, M’boyba Diop, Bastien Job, Gérôme Jules-Clement, Franck Le-Layo.

• "Core Service" bioinformaticians (non-permanent employees) : Marine Aglave, Edi Tihic

Bioinformatics core facility - Activities

• Analysis of (epi)genomic / transcriptomic sequencing data (WGS / WES / TGS, RNA-seq, ChIP / ATAC-seq, Single-Cell, Long Reads)
• Data management (recovery, centralization, organization, labeling, provision / sharing)
• Support to bioinformaticians, biologists, and clinicians from Gustave Roussy
• Publication assistance (material and methods, figures, deposit of data on public databases such as GEO / SRA / EGA / dbGAP)
• Co-supervision of junior bioinformaticians (trainees, PhD students…)

Credits

Création, développement et hébergement

1bis - 3, Boulevard Richard Lenoir
75011 Paris
Tel: +33 (0)1 55 38 16 60
www.akoa.fr

Photographies

Gustave Roussy
Nicolas Guerbe
Stéphanie Têtu
Elisabeth Bret-Sayer

Safety of administered health-care

The quality and safety of care are a priority at Gustave Roussy.

Medical advances over the last 20 years have brought major innovations in technology, drugs, surgery, etc.

These advances, as with any medical practice, always carry a risk.  

That is why, whenever diagnostic and therapeutic procedures are carried out during your care, the health-care professionals always have in mind the benefits that they may bring you but also the risks they carry and the side effects which might follow.

Lab members

Lab head
Prof. Nathalie Chaput-Gras
Email

Lab manager
Dr Lydie Cassard

Assistant professor
Dr Marie Naigeon

Engineer
Jean Jouniaux:

Engineer
Lisa Boselli

Technician
Jonathan Grivel:

Equipments

• 1 MACSQuant 16 Cytometer – Miltenyi Biotec Inc.
• 1 CytoFLEX S base Cytometer – Beckman Coulter
• 2 GALLIOS Cytometer – Beckman Coulter
• MAGPIX Multiplexing System – Luminex B.V.
• MESO QuickPlex SQ 120 – Meso Scale Discovery (LRTI)
• GentleMACS Dissociator - Miltenyi Biotec Inc.
• Vi-CELL XR Cell Analyzer – Beckman Coulter
• xCELLigence RTCA - Agilent

Vigilances sanitaires

Les vigilances sanitaires s’appliquent à l’ensemble des soins qui vous sont prodigués.

Identitovigilance

L’identitovigilance est un système de surveillance et de prévention des erreurs liées à l’identification des patients. Elle vise à garantir que tous les patients soient correctement identifiés tout au long de leur prise en charge dans l’hôpital et dans les échanges de données médicales et administratives. L’objectif est de fiabiliser l’identification du patient et les documents le concernant tout au long de la prise en charge.

Activities

The Laboratory of Immunomonitoring in Oncology (LIO), created at the end of 2014, is a translational research unit. The main objective of the laboratory is to identify blood or tumor biomarkers that can predict the response or resistance to anti-tumor immunotherapies, as well as the emergence of some immunological adverse effects that may be linked to these treatments. Another objective is to understand the mechanisms of action of anti-tumor immunotherapies.